Week of November 11, 2024

MMWR Weekly Briefing

Contenido proporcionado por U.S.Centers for Disease Control and Prevention(CDC) and CENTERS FOR DISEASE CONTROL. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente U.S.Centers for Disease Control and Prevention(CDC) and CENTERS FOR DISEASE CONTROL o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

1M ago 8:02

MP3•Episodio en casa

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on December 25, 2024 15:05 (11d ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

This episode discusses four MMWR reports. First, nirsevimab reduces the risk of severe RSV among Alaskan Native children, who have historically experienced high rates of RSV-associated hospitalizations. Second, a concerning decline in the use of antivirals is seen among children and teens hospitalized with flu. Third, measles cases are surging worldwide as vaccination coverage remains below pre-pandemic levels. Last, disease presentation, vaccination status, and recent international travel are important when suspected measles cases occur.

192 episodios

#Science #U.S.Centers for Disease Control and Prevention(CDC #Public Health #Coronavirus Disease 2019 #Hepatitis C #Influenza (flu #Malaria #Measles #Mmwr Summaries #Polio (poliomyelitis #Flu #Centers For Disease Control #In HIVAIDS #MMWR #Mpox #Opioid #On Covid19